AtriCure, Inc. - stock earnings
ATRC Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | -0.25 / -0.23 | - | 108.9 million / 109.0 million | - |
| July 23, 2024 BeforeMarket | - / - | 115.5 million | - / 116.2 million | 117.0 million |
ATRC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -13.3 million USD | 108.9 million USD |
| 2023Q4 | -9.8 million USD | 106.5 million USD |
| 2023Q3 | -9.1 million USD | 98.3 million USD |
| 2023Q2 | -5.1 million USD | 100.9 million USD |
| 2023Q1 | -6.5 million USD | 93.5 million USD |
| 2022Q4 | -4.2 million USD | 88.0 million USD |
| 2022Q3 | -12.3 million USD | 83.2 million USD |
| 2022Q2 | -14.8 million USD | 84.5 million USD |
| 2022Q1 | -15.2 million USD | 74.6 million USD |
| 2021Q4 | -13.7 million USD | 73.2 million USD |
| 2021Q3 | 97.1 million USD | 70.5 million USD |
| 2021Q2 | -16.3 million USD | 71.4 million USD |
| 2021Q1 | -16.9 million USD | 59.3 million USD |
| 2020Q4 | -18.6 million USD | 57.7 million USD |
| 2020Q3 | -4.9 million USD | 54.8 million USD |
| 2020Q2 | -8.2 million USD | 40.8 million USD |
| 2020Q1 | -16.4 million USD | 53.2 million USD |
| 2019Q4 | -16.1 million USD | 61.3 million USD |
| 2019Q3 | -9.4 million USD | 56.6 million USD |
| 2019Q2 | -4.1 million USD | 58.9 million USD |
| 2019Q1 | -5.6 million USD | 54.0 million USD |
| 2018Q4 | -3.4 million USD | 52.9 million USD |
| 2018Q3 | -7.2 million USD | 49.9 million USD |
| 2018Q2 | -338000 USD | 51.8 million USD |
| 2018Q1 | -10.1 million USD | 47.0 million USD |
| 2017Q4 | -2.6 million USD | 46.1 million USD |
| 2017Q3 | -7.2 million USD | 42.2 million USD |
| 2017Q2 | -6.9 million USD | 45.2 million USD |
| 2017Q1 | -10.2 million USD | 41.3 million USD |
| 2016Q4 | -8.6 million USD | 41.2 million USD |
| 2016Q3 | -6.8 million USD | 38.3 million USD |
| 2016Q2 | -8.2 million USD | 39.7 million USD |
| 2016Q1 | -9.7 million USD | 35.9 million USD |
| 2015Q4 | -10.9 million USD | 35.9 million USD |
| 2015Q3 | -6.1 million USD | 31.4 million USD |
| 2015Q2 | -4.9 million USD | 32.6 million USD |
| 2015Q1 | -5.3 million USD | 29.9 million USD |
| 2014Q4 | -5.3 million USD | 29.4 million USD |
| 2014Q3 | -466000 USD | 26.7 million USD |
| 2014Q2 | -2.7 million USD | 26.5 million USD |
| 2014Q1 | -7.7 million USD | 24.8 million USD |
| 2013Q4 | -5.0 million USD | 21.9 million USD |
| 2013Q3 | -2.7 million USD | 20.1 million USD |
| 2013Q2 | -1.8 million USD | 20.4 million USD |
| 2013Q1 | -1.9 million USD | 19.4 million USD |
| 2012Q4 | -2.0 million USD | 18.4 million USD |
| 2012Q3 | -2.6 million USD | 16.1 million USD |
| 2012Q2 | -1.3 million USD | 18.3 million USD |
| 2012Q1 | -1.6 million USD | 17.5 million USD |
| 2011Q4 | -2.1 million USD | 16.8 million USD |
| 2011Q3 | -1.2 million USD | 15.2 million USD |
| 2011Q2 | -946650 USD | 16.8 million USD |
| 2011Q1 | -1.3 million USD | 15.6 million USD |
| 2010Q4 | 11544 USD | 16.4 million USD |
| 2010Q3 | -1.0 million USD | 14.5 million USD |
| 2010Q2 | -764506 USD | 14.2 million USD |
| 2010Q1 | -2.0 million USD | 14.0 million USD |
| 2009Q4 | -2.4 million USD | 13.8 million USD |
| 2009Q3 | -4.7 million USD | 13.3 million USD |
| 2009Q2 | -1.4 million USD | 13.8 million USD |
| 2009Q1 | -8.0 million USD | 13.7 million USD |
| 2008Q4 | -3.2 million USD | 12.1 million USD |
| 2008Q3 | -1.8 million USD | 14.8 million USD |
| 2008Q2 | -1.6 million USD | 14.9 million USD |
| 2008Q1 | -3.6 million USD | 13.5 million USD |
| 2007Q4 | -1.6 million USD | 13.2 million USD |
| 2007Q3 | -2.6 million USD | 12.1 million USD |
| 2007Q2 | -2.8 million USD | 12.4 million USD |
| 2007Q1 | -4.3 million USD | 10.6 million USD |
| 2006Q4 | -4.3 million USD | 10.6 million USD |
| 2006Q3 | -3.2 million USD | 9.4 million USD |
| 2006Q2 | -3.2 million USD | 9.6 million USD |
| 2006Q1 | -3.1 million USD | 8.6 million USD |
| 2005Q4 | -4.0 million USD | 8.6 million USD |
| 2005Q3 | -4.0 million USD | 7.2 million USD |
| 2005Q2 | -2.3 million USD | 7.7 million USD |
| 2005Q1 | -2.4 million USD | 7.5 million USD |
| 2004Q4 | -6.4 million USD | 5.7 million USD |
| 2004Q3 | -1.7 million USD | 4.5 million USD |
| 2004Q2 | -197389 USD | 5.1 million USD |
| 2004Q1 | ? USD | 3.8 million USD |
| 2003Q4 | ? USD | 9.8 million USD |
ATRC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.4 million USD | 399.2 million USD |
| 2022 | -46.5 million USD | 330.4 million USD |
| 2021 | 50.2 million USD | 274.3 million USD |
| 2020 | -48.2 million USD | 206.5 million USD |
| 2019 | -35.2 million USD | 230.8 million USD |
| 2018 | -21.1 million USD | 201.6 million USD |
| 2017 | -26.9 million USD | 174.7 million USD |
| 2016 | -33.3 million USD | 155.1 million USD |
| 2015 | -27.2 million USD | 129.8 million USD |
| 2014 | -16.2 million USD | 107.5 million USD |
| 2013 | -11.5 million USD | 81.9 million USD |
| 2012 | -7.5 million USD | 70.2 million USD |
| 2011 | -5.5 million USD | 64.4 million USD |
| 2010 | -3.8 million USD | 59.0 million USD |
| 2009 | -16.5 million USD | 54.5 million USD |
| 2008 | -10.2 million USD | 55.3 million USD |
| 2007 | -11.3 million USD | 48.3 million USD |
| 2006 | -13.7 million USD | 38.2 million USD |
| 2005 | -12.7 million USD | 31.0 million USD |
| 2004 | -9.5 million USD | 19.2 million USD |
| 2003 | -7.1 million USD | 9.8 million USD |
| 2002 | -9.0 million USD | 1.8 million USD |
| 2001 | -3.6 million USD | 20000 USD |
ATRC
Price: $22.10
52 week price:
Earnings Per Share: -0.66 USD
P/E Ratio: -63.35
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 186700
Ebitda: -4.4 millionMarket Capitalization: 1.1 billion